Twitter Logo Youtube Circle Icon LinkedIn Icon

China > Healthcare and life sciences > PRC firms > Law firm and leading lawyer rankings


Index of tables

  1. Healthcare and life sciences: PRC firms
  2. Leading individuals

Leading individuals

  1. 1
    • Alan Zhou - Global Law Office

Who Represents Who

Find out which law firms are representing which PRC firms clients in China using The Legal 500's new comprehensive database of law firm/client relationships. Instantly search over 925,000 relationships, including over 83,000 Fortune 500, 46,000 FTSE350 and 13,000 DAX 30 relationships globally. Access is free for in-house lawyers, and by subscription for law firms. For more information, contact


With a formidable presence in the healthcare and life sciences sectors, Global Law Office’s practice is particularly strong in M&A, financing and public hospital restructurings. It regularly acts as PRC counsel for multinational clients in big-ticket cross-border mandates. For example, in 2016, the team advised Panasonic Healthcare/KKR on its $2bn acquisition of the diabetes care business of Bayer, and handled BeiGene’s $2.5bn acquisition of Celgene China Entity and the China license rights of three onocology products of Celgene. The group also handles a number of domestic deals; among them, it advised Beijing HG Healthcare Investment Management on the series-B financing of Beijing Nuokangda Pharmaceutical Technology and assisted a venture capital firm with its series-B investment in a Chinese pharmaceutical company. Alan Zhou specialises in M&A and compliance issues; Michael Yu has notable experience in M&A, IPOs and restructurings, and acts for private equity funds, listed companies, industrial investors and SOEs; and Weiwei Gu handles anti-bribery investigations. Bojia Zhao is also highly recommended.

King & Wood Mallesons’ ‘outstanding’ healthcare group advises on the full spectrum of matters including IP, regulatory, corporate and commercial and competition issues. Among its diverse workload, a multi-jurisdictional team assisted Shanghai Pharmaceuticals and Primavera Capital Group with their joint acquisition of Vitaco; private equity specialist Mulong Gong acted for a consortium of private equity investors on their RMB580m investment in Neusoft’s two subsidiaries Medical and Xikang, and assisted Shanghai Genext Pharmaceutical Technology with its RMB580m acquisition of UK-listed US company Lifeline Scientific. The capital markets team acted as PRC counsel for China Resources Pharmaceutical Group during its successful listing on the Hong Kong Stock Exchange (making it the largest IPO conducted by non-financial enterprises in Hong Kong’s capital markets in 2016), and advised Berry Genomics on its successful completion of back-door listing by investing RMB4.3bn assets into A-share listed company Chengdu Tianxing Instrument and Meter. Harry Liu represented a private-owned hospital in a bribery investigation; and Zhongsheng Li and Xinyue Song acted for Beijing Sihuan Pharmaceutical in its patent infringement dispute against Qilu Pharmaceutical. The team is jointly led by JianpinWang and Jianwen Huang.

Leveraging its particular expertise in the private equity and venture capital space, Han Kun Law Offices advises a steady stream of major funds, including Vivo Capital, Sequoia Capital, LYFE Capital, Cenova Ventures on matters concerning their investments in China’s healthcare sector. Huan Wang advised Taikang Insurance Group on its RMB1.1bn investment in IHH’s business in China, while Charles Li is assisting Universal Medical Financial & Technical Advisory Services with the joint investment in International Land Port Hospital with the First Affiliated Hospital of Xi’an Jiaotong University; Li also acted for a mobile medical company during its Series B equity financing. Shanghai-based Min Zhu and Kelvin Gao focus on the formation and deployment of private equity funds, M&A and corporate matters. The client roster also includes ResMed, Abbvie Pharmaceuticals, OrbiMed Asia Partners and SinoPharm Group.

JunHe LLP is well versed in healthcare transactional, regulatory, IP and contentious matters. Rui Feng, for example, advises multinational companies, Chinese SOEs and private equity funds on their cross-border M&A transactions, joint ventures, private placements, divestments and restructuring matters. In 2017, Feng and Yisong Yi advised BeiGene and Guangzhu GET Technology Development on establishing a Sino-foreign joint venture. Fan Yang acts for life sciences and healthcare companies as well as a number of private equity/venture investment institutions.

Zhong Lun Law Firm advises a range of healthcare providers and pharmaceutical companies on corporate and securities transactions, and is also recommended for patent mandates, litigation and enforcement matters. The firm assisted key client Abbott Laboratories with a range of patent issues, advised Shenzhen Gosun Pharmaceutical on its licensing agreement and drug registration relating to fifth generation cephalosporin antibiotics, and defended a domestic pharmaceutical company in a patent infringement claim filed by a foreign company. IP specialist Helen Cheng handles litigation, licensing and technology transfers, and IP enforcement strategies, and Will Wang is a key name for contentious IP matters.

Tahota Law Firm specialises in defending hospitals in high-profile product liability and medical malpractice claims; its practice also spans hospital mergers and acquisitions, equity transfer, restructurings and employment issues. Recent work includes representing Chengdu Eleventh People’s Hospital in litigation alleging death resulting from the use of certain medicine. Di Wu heads the department.

GC Powerlist -
China and Hong Kong

Press releases

The latest news direct from law firms. If you would like to submit press releases for your firm, send an email request to

Legal Developments in China

Legal Developments and updates from the leading lawyers in each jurisdiction. To contribute, send an email request to

Press Releases worldwide

The latest news direct from law firms. If you would like to submit press releases for your firm, send an email request to